|
After entering the
WTO, the Chinese pharmaceutical industry will enter a new structurer.
1) Competition in
China means the competition in the world: After WTO China will becomes
the major production base of bulk pharmaceutical and preparation; the
import & export will increase greatly; the gap between the Chinese product
and oversea product will be shorten; and the competition will be severe
and the domestic competition means the international competition.
2)Large enterprises
will emerge in the next few years: After WTO, maybe 5 year later, some
large enterprises, especially those that are listed in stock market, will
form and their capability will increase to an extent to compete with oversea
companies.
3) Medicine enterprises
will engage in multiple business areas.
4) Young men who are
expertizing in management will take resposibility in leadership position.
5)The function of
government will focus on the economic planning, market supervision and
society service.
6) Traditional pharmaceutical
industry will combine with the modern technique like network for a better
development.
7)The number of enterprise
will decrease by about one third in the next 5 years due to the reconstructure
or the incorporation.
8)The development
of new pharmaceuticals that have Chinese intellegene will be faster than
ever, in the sections like TCM, biochemical, bioengineering pharma, gene
chip, nutritional tonics, pharmaceutical new materials, etc.
9)The price of medicine
will decrease due to the mass supply but it is normal that the price of
new drug is higher than the ordinary drug.
10) Western area will
become the production base for the bulk pharmaceutical production due
to the cheap labor, cheap production cost and diversity of natural resources.
|